UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD)
CUSIP: 917488108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 3,189,220
- Total 13F shares
- 2,402,050
- Share change
- -98,196
- Total reported value
- $160,517,663
- Price per share
- $66.81
- Number of holders
- 99
- Value change
- -$6,987,298
- Number of buys
- 53
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 917488108?
CUSIP 917488108 identifies UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 917488108:
Top shareholders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
12%
|
393,045
|
$27,949,429 | — | 31 Mar 2024 | |
| Kevin L. Cornwell |
3/4/5
|
Chairman, CEO, Secretary, Director |
—
class O/S missing
|
188,472
|
$17,774,794 | — | 22 Nov 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
7.3%
|
232,514
|
$16,534,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.7%
|
214,397
|
$15,245,771 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
183,141
|
$13,023,157 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.1%
|
161,610
|
$11,492,087 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
80,658
|
$5,757,769 | — | 31 Mar 2024 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
2.5%
|
80,449
|
$5,720,728 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
73,679
|
$5,239,943 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.3%
|
72,552
|
$5,159,173 | — | 31 Mar 2024 | |
| BRANDES INVESTMENT PARTNERS, LP |
13F
|
Company |
2.2%
|
70,097
|
$4,984,598 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
2%
|
64,614
|
$4,594,702 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
50,602
|
$3,598,308 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
48,909
|
$3,477,935 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
48,213
|
$3,428,463 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
42,001
|
$2,986,692 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
1.3%
|
41,836
|
$2,974,957 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
39,218
|
$2,788,792 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
37,060
|
$2,635,337 | — | 31 Mar 2024 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
35,620
|
$2,532,938 | — | 31 Mar 2024 | |
| ISTHMUS PARTNERS, LLC |
13F
|
Company |
1.1%
|
35,602
|
$2,531,658 | — | 31 Mar 2024 | |
| Quadrature Capital Ltd |
13F
|
Company |
1%
|
32,310
|
$2,294,333 | — | 31 Mar 2024 | |
| Clean Yield Group |
13F
|
Company |
0.99%
|
31,714
|
$2,255,183 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.83%
|
26,450
|
$1,880,860 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.72%
|
22,941
|
$1,632,000 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.71%
|
22,700
|
$1,614,197 | — | 31 Mar 2024 | |
| BARD ASSOCIATES INC |
13F
|
Company |
0.61%
|
19,419
|
$1,386,576 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.51%
|
16,251
|
$1,155,609 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.51%
|
16,203
|
$1,152,195 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.47%
|
14,877
|
$1,058,000 | — | 31 Mar 2024 | |
| Cardinal Capital Management |
13F
|
Company |
0.46%
|
14,737
|
$1,051,538 | — | 31 Mar 2024 | |
| EVERETT HARRIS & CO /CA/ |
13F
|
Company |
0.45%
|
14,338
|
$1,019,575 | — | 31 Mar 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.43%
|
13,821
|
$983,000 | — | 31 Mar 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
13,086
|
$930,545 | — | 31 Mar 2024 | |
| Penn Mutual Asset Management |
13F
|
Company |
0.4%
|
12,898
|
$917,177 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.36%
|
11,329
|
$805,621 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.32%
|
10,091
|
$717,571 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
9,729
|
$691,829 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.3%
|
9,632
|
$684,932 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.29%
|
9,398
|
$668,292 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.26%
|
8,399
|
$597,253 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
7,700
|
$547,547 | — | 31 Mar 2024 | |
| Ernst G. Hoyer |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$471,550 | — | 23 Nov 2021 | |
| Barbara A. Payne |
3/4/5
|
Director |
—
class O/S missing
|
4,838
|
$456,272 | — | 08 Feb 2023 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.2%
|
6,336
|
$450,553 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.19%
|
6,023
|
$428,296 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.17%
|
5,455
|
$387,906 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.17%
|
5,303
|
$377,096 | — | 31 Mar 2024 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
5,129
|
$364,741 | — | 31 Mar 2024 | |
| SHERBROOKE PARK ADVISERS LLC |
13F
|
Company |
0.16%
|
5,064
|
$360,101 | — | 31 Mar 2024 |
Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q2 2024
As of 30 Jun 2024,
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,402,050 shares.
The largest 10 holders included
FMR LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BRANDES INVESTMENT PARTNERS, LP, GEODE CAPITAL MANAGEMENT, LLC, Ranger Investment Management, L.P., STATE STREET CORP, and RICE HALL JAMES & ASSOCIATES, LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
99
Q2 2024 holders
99
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.